Impel Pharmaceuticals

is developing and providing transformative therapies that have the potential to improve the lives of patients all over the world.

This is just the beginning. Impel Pharmaceuticals is committed to harnessing this potential beyond our current core indication. Impel is actively considering partnerships, collaborations and licensing opportunities to explore the therapeutic potential of our technology and expertise with both small and large molecules.


We believe the upper nasal space to be a gateway for improved absorption and hence, the potential for enhanced clinical outcomes.
The POD devices are designed to deliver a range of therapeutic molecules and formulations deep into the vascular-rich upper nasal space. This unique combination has the potential to deliver consistent and predictable doses of drug, potentially enabling on-demand access for molecules previously limited to injection and hospital-based use.